MKKGY Merck KGaA
Merck KGaA (MKKGY) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $0.47 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -5.0% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Merck KGaA
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Sector
Healthcare
Industry
Drug Manufacturers/Other